2023
DOI: 10.1016/j.ijpharm.2023.122591
|View full text |Cite
|
Sign up to set email alerts
|

Microneedles as a momentous platform for psoriasis therapy and diagnosis: A state-of-the-art review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(15 citation statements)
references
References 129 publications
0
10
0
Order By: Relevance
“…[187,188] Despite these advantages, it is challenging to load high concentrations of lipophilic drugs into MNs. [189] In this regard, incorporating solubility-enhanced anticancer drugs via NSs into dissolving, coated, and hydrogel-forming MNs could overcome one of the most significant drawbacks of MNs, i.e., low drug loading capacity. Furthermore, the NSs-loaded MN patch could be utilized to treat cutaneous skin cancer and breast cancer.…”
Section: Conclusion and Future Perspectivementioning
confidence: 99%
“…[187,188] Despite these advantages, it is challenging to load high concentrations of lipophilic drugs into MNs. [189] In this regard, incorporating solubility-enhanced anticancer drugs via NSs into dissolving, coated, and hydrogel-forming MNs could overcome one of the most significant drawbacks of MNs, i.e., low drug loading capacity. Furthermore, the NSs-loaded MN patch could be utilized to treat cutaneous skin cancer and breast cancer.…”
Section: Conclusion and Future Perspectivementioning
confidence: 99%
“…10,11 Because of their painless, minimally invasive, and user-friendly feature, several MAPs have been developed for the transdermal delivery of MTX for psoriasis treatment. 12 For example, Du et al developed a dissolvable microneedle array patch (MAP) loaded with methotrexate (MTX) based on hyaluronic acid (HA). 13 These patches have proven to be more effective than orally taking the same dose of the drug in mitigating psoriatic symptoms.…”
Section: Introductionmentioning
confidence: 99%
“…Microneedles (MNs) or microneedle array patches (MAPs) have emerged as the primary method for transdermal drug delivery, garnering substantial global interest in recent times . These tiny projections can penetrate the skin’s stratum corneum barrier, allowing for precise drug delivery to the viable epidermis and dermal layers while avoiding stimulation of blood vessels or nerve endings. , Because of their painless, minimally invasive, and user-friendly feature, several MAPs have been developed for the transdermal delivery of MTX for psoriasis treatment . For example, Du et al developed a dissolvable microneedle array patch (MAP) loaded with methotrexate (MTX) based on hyaluronic acid (HA) .…”
Section: Introductionmentioning
confidence: 99%
“…MN devices consist of micron‐sized needles arranged in a collection on a patch with appropriate mechanical strength, toughness, and length to break through the SC for drug delivery while ensuring painlessness and minimal invasiveness due to their small size, resulting in good patient compliance and improved efficacy. [ 4 ] With the breakthrough of smart biomaterials, MNs have the functions of biosignal sensing, [ 5 ] drug dosage control, [ 6 ] drug response release, [ 7 ] vaccine delivery, [ 8 ] diagnostics, [ 9 ] etc., which bring more possibilities for biomedical and other research fields. And the MN array encapsulated with responsive nanoparticles (NPs) combines the MN and NP strategies with the advantages of good drug stability, high bioavailability, and good targeting, which has received more and more attention as a multifunctional platform in TDD systems.…”
Section: Introductionmentioning
confidence: 99%